Post-Traumatic Stress Disorder Treatment Market to Reach $26.1 Bn, Globally, by 2031 at 4.9% CAGR: Allied Market Research

Increase in the number of clinical trials pertaining to post-traumatic stress disorder treatment and rise in R&D activities for the introduction of novel therapies and drugs drive the growth of the global post-traumatic stress disorder treatment market.

PORTLAND, Ore., July 26, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, 'Post-Traumatic Stress Disorder Treatment Market by Treatment Type (Drugs, Pyschotherapy), By Age Group (Pediartic, Geriatric, Adult), By End User (Hospitals, Outpaitent Clinics, Mental Health Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global post-traumatic stress disorder treatment industry was estimated at $16.0 billion in 2021, and is anticipated to hit $26.1 billion by 2031, registering a CAGR of 4.9% from 2022 to 2031.

Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/12965

Prime determinants of growth-

Increase in the number of clinical trials pertaining to post-traumatic stress disorder treatment and rise in R&D activities for the introduction of novel therapies and drugs drive the growth of the global post-traumatic stress disorder treatment market. Moreover, surge in government initiatives for post-traumatic stress disorder treatment & management and growing healthcare expenditure in developing countries are expected to pave the way for lucrative opportunities in the industry.

Covid-19 Scenario-

• During the global health crisis, a large number of patients witnessed a decline in psychotherapies, which in turn gave way to increasing adoption of drugs and medication intended for the treatment of the post-traumatic disorder treatment market. This factor impacted the market positively.
• This trend is going to continue until the pandemic is over.

Scope of the Report: -

The psychotherapy segment to dominate by 2031-

By treatment type, the psychotherapy segment contributed to the major share in 2021, holding more than two-thirds of the global post-traumatic stress disorder market. Rise in the prevalence of post-traumatic stress disorder and the surge in initiatives by governments for treating their war veterans have led to increased demand for PTSD therapeutics across the world, thus propelling the segment growth. The drugs segment, however, would cite the fastest CAGR of 6.5% during the forecast period.

Specific Requirement on COVID-19? Ask to Our Industry Expert:
https://www.alliedmarketresearch.com/request-for-customization/12965?reqfor=covid

The adult segment to maintain the lion's share-

By age group, the adult segment accounted for the major share in 2021, holding nearly half of the global post-traumatic stress disorder market. Rise in violence, cross-border tensions, accidents, and occupational hazards across the world fuel the growth of the segment. The pediatric segment, on the other hand, is expected to grow at the fastest CAGR of 5.9% from 2022 to 2031, due to increase in mental and physical abuse cases.

North America Post-Traumatic Stress Disorder Treatment Market Garnered the Major Share in 2021-

By region, the market across North America had the lion's share in 2021, generating around two-fifths of the global post-traumatic stress disorder market. This is attributed to the increasing burden of post-traumatic stress disorders, rise in research and development activities, and presence of strong and established market players across the province. Asia-Pacific, simultaneously, is projected to portray the fastest CAGR of 6.2% by 2031, owing to surge in number of mental and sexual abuse among adults in the region.

Key players in the industry-

• Behavioral Health Network, Inc.
• CareTech Holdings Plc
• GlaxoSmithKline Plc
• Viatris, Inc
• North Range Behavioral Health
• Strategic Behavioral Health
• Pyramid Healthcare
• Pfizer, Inc
• Eily Lilly and Company
• Acadia Healthcare
• Ascension Seton

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the post-traumatic stress disorder treatment market analysis from 2021 to 2031 to identify the prevailing post-traumatic disorder treatment market opportunities.
• The Market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the post-traumatic stress disorder treatment market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global post-traumatic disorder treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

• By Treatment Type
• Drugs
• Pyschotherapy
  
  
• By Age Group
• Pediartic
• Geriatric
• Adult
  
  
• By End User
• Mental Health Center
• Others
• Hospitals
• Outpaitent Clinics
  
  
• By Region
• North America
• U.S.
• Canada
• Mexico
• Europe
• Spain
• Rest of Europe
• Germany
• France
• U.K.
• Italy
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Rest Of Asia Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):

mHealth Market size was valued at $ 46,048 million in 2019, and is projected to reach $ 230,419 million by 2027, registering a CAGR of 22.3% from 2020 to 2027.

Advanced Wound Care Market size was valued at $8,978.0 million in 2020, and is projected to reach $14,190.5 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.

Medical Tourism Market size accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.

Disposable Gloves Market size was valued at $10,248.09 million in 2019, and is projected to reach $29,807.71 million by 2030, registering a CAGR of 4.78%.

Gene Therapy Market Size was valued at $6.0 billion in 2020 and is projected to reach $46.5 billion by 2030, growing at a CAGR of 22.8% from 2021 to 2030.

Telemedicine Market size was valued at $40,205.68 million in 2020, and is estimated to reach $431,823.81 million by 2030, growing at a CAGR of 25.90% from 2021 to 2030.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences 
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/ 

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

SOURCE Allied Market Research

21%

more press release views with 

Request a Demo